Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2017 Sep 28;155(2):670–678.e1. doi: 10.1016/j.jtcvs.2017.09.089

Table 2.

Postoperative characteristicsa

C. diff
(N = 50)
No C. diff
(N = 5108)
Overall
(N = 5158)
Hazard
Ratio
P-valueb
Days of post-operative antibiotic prophylaxis <.0001
  2 Days (24–48 hours) 13 (26.0) 2107 (41.2) 2120 (41.1)
  1 Day (0–24 hours) 11 (22.0) 2585 (50.6) 2596 (50.3) 0.692
  3 Days (>48 hours) 26 (52.0) 416 (8.1) 442 (8.6) 10.033
Post-operative antibiotic prophylaxis 0.0358
  1st generation cephalosporin 19 (38.0) 1721 (33.7) 1740 (33.7) 0.721
  2nd generation cephalosporin 14 (28.0) 2270 (44.4) 2284 (44.3) 0.404
  Other 17 (34.0) 1117 (21.9) 1134 (22.0)
ICU days 5.0 (2.0, 8.0) 2.0 (1.0, 3.0) 2.0 (1.0, 3.0) 1.069 <.0001
Ventilation duration, days 1.0 (0.6, 2.1) 0.6 (0.4, 1.0) 0.6 (0.4, 1.0) 1.087 0.0001
Packed red blood cells, unitc 2.0 (0.0, 8.0) 0.0 (0.0, 3.0) 0.0 (0.0, 3.0) 1.225 <.0001
LOS from surgery (truncated at onset of C. diff), days 10.0 (7.0, 17.0) 7.0 (6.0, 10.0) 7.0 (6.0, 10.0) 1.069 <.0001
Non- C. difficile infectiond 14 (28.0) 551 (10.8) 565 (11.0) 3.180 0.0002
Hyperglycemia 37 (74.0) 2191 (43.0) 2228 (43.3) 3.766 <.0001
a

Continuous variables are expressed as median (IQR). Categorical variable is described as count (%).

b

Based on Cox proportional hazards model where outcome is time to C. diff infection and predictor is postoperative characteristic.

c

48.1% of patients received packed red blood cell transfusions.

d

Onset of non- C. difficile infection prior to onset of CDI for C. difficile patients.